| Literature DB >> 29262867 |
Nancy A Kassam1, Damian J Damian2,3, Debora Kajeguka1, Balthazar Nyombi1,4, Gibson S Kibiki4,5.
Abstract
OBJECTIVE: This study aimed to determine the spectrum and antibiogram of the isolated bacteria from patients presenting with infected wounds at Kilimanjaro Christian Medical Centre in northern Tanzania.Entities:
Keywords: Antibiogram; Diabetic wounds; Drug resistance pattern; ESBL; Surgical site infection; Trauma wounds; Wound infection
Mesh:
Substances:
Year: 2017 PMID: 29262867 PMCID: PMC5738783 DOI: 10.1186/s13104-017-3092-9
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Fig. 1Species of bacteria isolated
Drug resistance patterns of Gram positive isolates
| Antibiotics | Gram positive isolate (%) | ||
|---|---|---|---|
|
| CNS |
| |
| Amoxicillin | 61.9a | 33.3a | 35.7a |
| Amoxicillin–clavulanate | NT | 57.1 | 47.1 |
| Ceftriaxone | 21.7 | 33.3a | NT |
| Ciprofloxacin | 4.3 | 0.0a | 31.3a |
| Gentamycin | 17.4 | 0.0 | NT |
| Clindamycin | 14.3a | 0.0 | NT |
| Erythromycin | 45.0a | 42.9 | 42.9a |
NT, not tested; CNS, Coagulase negative Staphylococcus
aNot all bacteria were tested against a particular drug
Antibiotic resistance patterns for Gram negative rods isolated (n = 91)
| Antibiotics | Gram negative rods isolated (%) | ||||||
|---|---|---|---|---|---|---|---|
| K. PN | K. OX | P. MR | P. SP | P. AE | E. CL | O. COL | |
| Amikacin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00a | 4.0 |
| Amoxicillin–clavulanate | 100.0 | 100.0 | 80.0 | 66.7a | 100.0 | 92.9 | 96.6 |
| Ceftazidime | 70.0 | 20.0 | 12.5a | 33.3a | 25.0 | 18.2a | 72.0 |
| Ceftriaxone | 70.0 | 20.0 | 37.5a | 22.2 | 21.4 | 38.5a | 64.0 |
| Ciprofloxacin | 30.0 | 20.0 | 0.00 | 0.00a | 0.00 | 35.7 | 36.0 |
| Cotrimoxazole | 100.0 | 80.0 | 66.7a | 77.8a | 92.9 | 84.6a | 84.0 |
| Gentamycin | 50.0 | 60.0 | 40.0 | 22.2 | 28.5 | 50.0 | 52.0 |
| Cefotaxime | 66.7a | 0.00a | 50.0a | 55.5a | 58.33 | 45.5a | 70.8a |
Gram-negative rods isolated: K. PN, Klebsiella pneumoniae; K. OX, Klebsiella oxytoca; P. MR, Proteus mirabilis; P. SP, Proteus species; P. AE, Pseudomonas aeruginosa; E. CL, Escherichia coli; O. COL, Other Coliforms; Acinetobacter spp.; Citrobacter spp.; Morganella spp.
aNot all bacteria were tested against a particular drug